ZURA
Zura Bio Limited · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +6.6% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 44 | +6 | 19.12M | $111.66M | +15 | −9 |
| Q1 2026 | 39 | +4 | 16.55M | $97.28M | +6 | −2 |
| Q4 2025 | 35 | -1 | 16.01M | $83.89M | — | −1 |
| Q3 2025 | 16 | +3 | 16.65M | $72.09M | +3 | — |
| Q2 2025 | 10 | -1 | 5.96M | $6.26M | — | −1 |
| Q1 2025 | 8 | -1 | 4.76M | $6.14M | +1 | −2 |
| Q4 2024 | 9 | 0 | 5.19M | $12.99M | +1 | −1 |
| Q3 2024 | 8 | +2 | 3.98M | $16.15M | +2 | — |
| Q2 2024 | 6 | — | 3.73M | $12.85M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 2.41M | 0.0% | $9.80M | 0.0% | Held | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 912.62K | +70.6% | $3.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 912.62K | +70.6% | $3.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 336.83K | -46.8% | $1.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 176.97K | +50.3% | $718,510 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 63.90K | +267.2% | $259,434 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 43.86K | New | $178,063 | 0.0% | New | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 15.32K | New | $63,000 | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 14.50K | +17.7% | $58,878 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 14.50K | +17.7% | $58,878 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 14.50K | +17.7% | $58,878 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $178,063 | 0.0% |
| T. Rowe Price | $63,000 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 92 holders, 61.32M shares, $364.31M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.